Heterogeneity in [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Non–Small Cell Lung Carcinoma and Its Relationship to Metabolic Parameters and Pathologic Staging
Open Access
- 1 November 2014
- journal article
- Published by SAGE Publications in Molecular Imaging
- Vol. 13 (9)
Abstract
To investigate the relationships between tumor heterogeneity, assessed by texture analysis of [18F]fluorodeoxyglucose–positron emission tomography (FDG-PET) images, metabolic parameters, and pathologic staging in patients with non-small cell lung carcinoma (NSCLC). A retrospective analysis of 38 patients with histologically confirmed NSCLC who underwent staging FDG-PET/computed tomography was performed. Tumor images were segmented using a standardized uptake value (SUV) cutoff of 2.5. Five textural features, related to the heterogeneity of gray-level distribution, were computed (energy, entropy, contrast, homogeneity, and correlation). Additionally, metabolic parameters such as SUVmax, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG), as well as pathologic staging, histologic subtype, and tumor diameter, were obtained. Finally, a correlation analysis was carried out. Of 38 tumors, 63.2% were epidermoid and 36.8% were adenocarcinomas. The mean ± standard deviation values of MTV and TLG were 30.47 ± 25.17 mL and 197.81 ± 251.11 g, respectively. There was a positive relationship of all metabolic parameters (SUVmax, SUVmean, MTV, and TLG) with entropy, correlation, and homogeneity and a negative relationship with energy and contrast. The T component of the pathologic TNM staging (pT) was similarly correlated with these textural parameters. Textural features associated with tumor heterogeneity were shown to be related to global metabolic parameters and pathologic staging.Keywords
This publication has 41 references indexed in Scilit:
- Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer PrognosisAsian Pacific Journal of Cancer Prevention, 2013
- Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Tumor heterogeneity and its implication for drug deliveryJournal of Controlled Release, 2012
- Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesEMBO Molecular Medicine, 2012
- Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancerNuclear Medicine Communications, 2012
- PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniquesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- A novel fuzzy C‐means algorithm for unsupervised heterogeneous tumor quantification in PETMedical Physics, 2010
- Tomografía por emisión de positrones de cuerpo completo (PET/TAC) con 18F-fluorodesoxiglucosaRevista Española de Medicina Nuclear, 2009
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008